JP7624999B2 - 乳房内投与によって使用される反芻動物のための獣医学抗プロラクチン組成物 - Google Patents

乳房内投与によって使用される反芻動物のための獣医学抗プロラクチン組成物 Download PDF

Info

Publication number
JP7624999B2
JP7624999B2 JP2022544228A JP2022544228A JP7624999B2 JP 7624999 B2 JP7624999 B2 JP 7624999B2 JP 2022544228 A JP2022544228 A JP 2022544228A JP 2022544228 A JP2022544228 A JP 2022544228A JP 7624999 B2 JP7624999 B2 JP 7624999B2
Authority
JP
Japan
Prior art keywords
cabergoline
ruminant
composition
administered
dairy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022544228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511147A5 (https=
JP2023511147A (ja
Inventor
バーテイム，ティエリー
ドフランドル，オードリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of JP2023511147A publication Critical patent/JP2023511147A/ja
Publication of JP2023511147A5 publication Critical patent/JP2023511147A5/ja
Application granted granted Critical
Publication of JP7624999B2 publication Critical patent/JP7624999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
JP2022544228A 2020-01-27 2021-01-26 乳房内投与によって使用される反芻動物のための獣医学抗プロラクチン組成物 Active JP7624999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20305066.1 2020-01-27
EP20305066 2020-01-27
PCT/EP2021/051766 WO2021151897A1 (en) 2020-01-27 2021-01-26 Veterinary anti-prolactin composition for ruminants used by intramammary administration

Publications (3)

Publication Number Publication Date
JP2023511147A JP2023511147A (ja) 2023-03-16
JP2023511147A5 JP2023511147A5 (https=) 2024-02-01
JP7624999B2 true JP7624999B2 (ja) 2025-01-31

Family

ID=69528716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544228A Active JP7624999B2 (ja) 2020-01-27 2021-01-26 乳房内投与によって使用される反芻動物のための獣医学抗プロラクチン組成物

Country Status (16)

Country Link
US (1) US20230063100A1 (https=)
EP (1) EP4096428B1 (https=)
JP (1) JP7624999B2 (https=)
KR (1) KR20220132561A (https=)
CN (1) CN115003164A (https=)
AR (1) AR122365A1 (https=)
AU (1) AU2021213891A1 (https=)
BR (1) BR112022014708A2 (https=)
CA (1) CA3165962A1 (https=)
ES (1) ES2969031T3 (https=)
HU (1) HUE064769T2 (https=)
IL (1) IL294903A (https=)
MX (1) MX2022009177A (https=)
UY (1) UY39022A (https=)
WO (1) WO2021151897A1 (https=)
ZA (1) ZA202207808B (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505178A (ja) 2008-10-07 2012-03-01 セヴァ・サンテ・アニマル 反芻動物のための獣医用抗プロラクチン組成物
US20140024670A1 (en) 2011-02-15 2014-01-23 Ceva Sante Animale Veterinary anti-prolactin composition for ruminants
US20190358154A1 (en) 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
CN106389964B (zh) * 2016-11-21 2019-05-14 四川农业大学 一种奶牛回乳药物组合

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505178A (ja) 2008-10-07 2012-03-01 セヴァ・サンテ・アニマル 反芻動物のための獣医用抗プロラクチン組成物
US20140024670A1 (en) 2011-02-15 2014-01-23 Ceva Sante Animale Veterinary anti-prolactin composition for ruminants
US20190358154A1 (en) 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M BOUTINAUD; ET AL，CABERGOLINE INHIBITS PROLACTIN SECRETION AND ACCELERATES INVOLUTION IN DAIRY COWS AFTER DRY-OFF，JOURNAL OF DAIRY SCIENCE，2015年，VOL:99, NR:7，PAGE(S):5707 - 5718，http://dx.doi.org/10.3168/jds.2015-10782
P LACASSE; ET AL，REVIEW: INHIBITION OF PROLACTIN AS A MANAGEMENT TOOL IN DAIRY HUSBANDRY，ANIMAL，英国，2019年07月，VOL:13, NR:S1，PAGE(S):S35 - S41，http://dx.doi.org/10.1017/S1751731118003312
乳房炎の化学療法 XI. 乳房に注入する薬物の浸透拡散について，日獣会誌，1957年，10，pp.129-133

Also Published As

Publication number Publication date
EP4096428B1 (en) 2023-10-11
MX2022009177A (es) 2022-08-17
BR112022014708A2 (pt) 2022-10-11
CA3165962A1 (en) 2021-08-05
AU2021213891A1 (en) 2022-08-18
CN115003164A (zh) 2022-09-02
HUE064769T2 (hu) 2024-04-28
WO2021151897A1 (en) 2021-08-05
ES2969031T3 (es) 2024-05-16
AR122365A1 (es) 2022-09-07
IL294903A (en) 2022-09-01
JP2023511147A (ja) 2023-03-16
KR20220132561A (ko) 2022-09-30
EP4096428C0 (en) 2023-10-11
UY39022A (es) 2021-07-30
EP4096428A1 (en) 2022-12-07
US20230063100A1 (en) 2023-03-02
ZA202207808B (en) 2023-03-29

Similar Documents

Publication Publication Date Title
CN102215843B (zh) 抗催乳素兽医学组合物在制备药物中的用途
EP2675527B1 (fr) Composition veterinaire antiprolactinique destinee aux ruminants comprenant la cabergoline
JP7624999B2 (ja) 乳房内投与によって使用される反芻動物のための獣医学抗プロラクチン組成物
RU2846098C1 (ru) Ветеринарная антипролактиновая композиция для жвачных животных, используемая путем введения в молочную железу
EP4096429B1 (en) Veterinary composition for dairy ruminants for treatment of milk fever
AU2013204272B2 (en) Veterinary Antiprolactinic Composition for Ruminants
HK1161555B (en) Use of an antiprolactinic veterinary composition for the manufacture of a medicament

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241224

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250121

R150 Certificate of patent or registration of utility model

Ref document number: 7624999

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150